For research use only. Not for therapeutic Use.
DL-Methyldopa-d3, a premium pharmaceutical research compound designed for advanced studies in antihypertensive and neurological research. As a deuterated analog of DL-Methyldopa, it offers enhanced stability and improved pharmacokinetic properties. DL-Methyldopa-d3 is ideal for use in pharmacological and biochemical research, providing precise and reliable data for your studies. This high-purity compound ensures consistent results, aiding in the development of novel therapies for hypertension and related cardiovascular conditions. Trusted by leading laboratories, DL-Methyldopa-d3 is your go-to solution for cutting-edge cardiovascular research. Unlock new possibilities in blood pressure management with DL-Methyldopa-d3, where innovation meets reliability.
| Catalog Number | S000171 |
| Molecular Formula | C10H10D3NO4 |
| Purity | ≥95% |
| IUPAC Name | 2-amino-3,3,3-trideuterio-2-[(3,4-dihydroxyphenyl)methyl]propanoic acid |
| InChI | InChI=1S/C10H13NO4/c1-10(11,9(14)15)5-6-2-3-7(12)8(13)4-6/h2-4,12-13H,5,11H2,1H3,(H,14,15)/i1D3 |
| InChIKey | CJCSPKMFHVPWAR-FIBGUPNXSA-N |
| SMILES | [2H]C([2H])([2H])C(CC1=CC(=C(C=C1)O)O)(C(=O)O)N |
| Reference | [1]. Russak EM, et al. Impact of Deuterium Substitution on the Pharmacokinetics of Pharmaceuticals. Ann Pharmacother. 2019;53(2):211-216. |
